People · Operator
Named in public records as an officer, director or promoter · active 2018–2023 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rodeo Therapeutics Corp | — | Biotechnology | Series A | $14.3M | $323.6M | 2018 |
| Automera US Inc. | — | Biotechnology | Series A | $12.2M | $95.1M | 2023 |
| KayoThera, Inc. | — | Other | Series A | $11.2M | $95.2M | 2022 |
Suzanne Rettenmier at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Suzanne Rettenmier on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Thong Le | 3 | 12 |
| Kendall Mohler | 3 | 5 |
| Ian Howes | 3 | 5 |
| Asish Xavier | 1 | 18 |
| Steve Gillis | 1 | 13 |
| Joel Marcus | 1 | 9 |
| Sean Cassidy | 1 | 7 |
| Lindsay Rayle | 1 | 7 |
| James Sullivan | 1 | 7 |
| David Schubert | 1 | 6 |
| Margarita Chavez | 1 | 4 |
| Mitchell Hymowitz | 1 | 4 |
| Tadataka Yamada | 1 | 2 |
| Mark Esposito | 1 | 2 |
| Katie Hewitt | 1 | 2 |
| Sanford Markowitz | 1 | 1 |
| Wen Qi Ho | 1 | 1 |
| Yu-Chieh Alice Chen | 1 | 1 |
| Benjamin Zian-Loong Wang | 1 | 1 |
| KEN MOHLER | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.